Your browser doesn't support javascript.
loading
Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose booster.
Nolan, Terry M; Deliyannis, Georgia; Griffith, Maryanne; Braat, Sabine; Allen, Lilith F; Audsley, Jennifer; Chung, Amy W; Ciula, Marcin; Gherardin, Nicholas A; Giles, Michelle L; Gordon, Tom P; Grimley, Samantha L; Horng, Lana; Jackson, David C; Juno, Jennifer A; Kedzierska, Katherine; Kent, Stephen J; Lewin, Sharon R; Littlejohn, Mason; McQuilten, Hayley A; Mordant, Francesca L; Nguyen, Thi H O; Soo, Vanessa Pac; Price, Briony; Purcell, Damian F J; Ramanathan, Pradhipa; Redmond, Samuel J; Rockman, Steven; Ruan, Zheng; Sasadeusz, Joseph; Simpson, Julie A; Subbarao, Kanta; Fabb, Stewart A; Payne, Thomas J; Takanashi, Asuka; Tan, Chee Wah; Torresi, Joseph; Wang, Jing Jing; Wang, Lin-Fa; Al-Wassiti, Hareth; Wong, Chinn Yi; Zaloumis, Sophie; Pouton, Colin W; Godfrey, Dale I.
Affiliation
  • Nolan TM; Department of Infectious Diseases, University of Melbourne at the Peter Doherty Institute for Infection & Immunity, Melbourne, Australia; Murdoch Children's Research Institute, Melbourne, Australia. Electronic address: t.nolan@unimelb.edu.au.
  • Deliyannis G; Department of Microbiology & Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Griffith M; Department of Infectious Diseases, University of Melbourne at the Peter Doherty Institute for Infection & Immunity, Melbourne, Australia.
  • Braat S; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia.
  • Allen LF; Department of Microbiology & Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Audsley J; Department of Microbiology & Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Chung AW; Department of Microbiology & Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Ciula M; Department of Microbiology & Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Gherardin NA; Department of Microbiology & Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Giles ML; Department of Infectious Diseases, University of Melbourne at the Peter Doherty Institute for Infection & Immunity, Melbourne, Australia.
  • Gordon TP; Department of Immunology, Flinders University and SA Pathology, Flinders Medical Centre, Bedford Park, Adelaide, Australia.
  • Grimley SL; Department of Microbiology & Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Horng L; Department of Infectious Diseases, University of Melbourne at the Peter Doherty Institute for Infection & Immunity, Melbourne, Australia; Murdoch Children's Research Institute, Melbourne, Australia.
  • Jackson DC; Department of Microbiology & Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Juno JA; Department of Microbiology & Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Kedzierska K; Department of Microbiology & Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia; Global Station for Zoonosis Control, Global Institution for Collaborative Research and Education (GI-CoRE), Hokkaido University, Sapporo, Japan.
  • Kent SJ; Department of Microbiology & Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Lewin SR; Department of Infectious Diseases, University of Melbourne at the Peter Doherty Institute for Infection & Immunity, Melbourne, Australia; Victorian Infectious Diseases Service, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia; Department of
  • Littlejohn M; Department of Infectious Diseases, University of Melbourne at the Peter Doherty Institute for Infection & Immunity, Melbourne, Australia.
  • McQuilten HA; Department of Microbiology & Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Mordant FL; Department of Microbiology & Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Nguyen THO; Department of Microbiology & Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Soo VP; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia.
  • Price B; Department of Infectious Diseases, University of Melbourne at the Peter Doherty Institute for Infection & Immunity, Melbourne, Australia; Murdoch Children's Research Institute, Melbourne, Australia.
  • Purcell DFJ; Department of Microbiology & Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Ramanathan P; Department of Microbiology & Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Redmond SJ; Department of Microbiology & Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Rockman S; Department of Microbiology & Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia; CSL Seqirus, Vaccine Innovation Unit, Parkville, Melbourne, Australia.
  • Ruan Z; Department of Microbiology & Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Sasadeusz J; Victorian Infectious Diseases Service, Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia; Department of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, Australia.
  • Simpson JA; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia.
  • Subbarao K; Department of Microbiology & Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia; WHO Collaborating Centre for Reference and Research on Influenza at the Peter Doherty Institute for Infection and Immunity, Australia.
  • Fabb SA; Monash Institute of Pharmaceutical Sciences, Parkville, Australia.
  • Payne TJ; Monash Institute of Pharmaceutical Sciences, Parkville, Australia.
  • Takanashi A; Monash Institute of Pharmaceutical Sciences, Parkville, Australia.
  • Tan CW; Duke NUS Medical School, Programme for Emerging Infectious Diseases, Singapore.
  • Torresi J; Department of Microbiology & Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Wang JJ; Department of Immunology, Flinders University and SA Pathology, Flinders Medical Centre, Bedford Park, Adelaide, Australia.
  • Wang LF; Duke NUS Medical School, Programme for Emerging Infectious Diseases, Singapore.
  • Al-Wassiti H; Monash Institute of Pharmaceutical Sciences, Parkville, Australia.
  • Wong CY; Department of Microbiology & Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Zaloumis S; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia.
  • Pouton CW; Monash Institute of Pharmaceutical Sciences, Parkville, Australia.
  • Godfrey DI; Department of Microbiology & Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
EBioMedicine ; 98: 104878, 2023 Dec.
Article in En | MEDLINE | ID: mdl-38016322
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Limits: Adolescent / Adult / Humans / Middle aged Country/Region as subject: Oceania Language: En Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Limits: Adolescent / Adult / Humans / Middle aged Country/Region as subject: Oceania Language: En Year: 2023 Type: Article